<?xml version="1.0" encoding="UTF-8"?>
<p>In the past few years, it has been established that sphingolipids play a vital protective role in lungs from pulmonary leak and lung injury, and the modulation of their pathways may offer effective therapeutic intervention strategies [
 <xref rid="B73-ijms-21-03544" ref-type="bibr">73</xref>]. Modulation of sphingolipids can be very beneficial and can offer an anti-inflammatory, neuroprotective, and anti-coagulant effects [
 <xref rid="B74-ijms-21-03544" ref-type="bibr">74</xref>,
 <xref rid="B75-ijms-21-03544" ref-type="bibr">75</xref>]. All of these exciting features could likely be exploited to counteract the associated complications of COVID-19 infection [
 <xref rid="B76-ijms-21-03544" ref-type="bibr">76</xref>].
</p>
